Showing results (2261-2270 of 4,124) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|December 24, 2010
Pigment epithelium-derived factor gene therapy targeting retinal ganglion cell injuries: neuroprotection against loss of function in two animal modelsMasanori Miyazaki, Yasuhiro Ikeda, Yoshikazu Yonemitsu, et al.Human Gene Therapy|January 18, 2011
PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1CT Goldmann, N Overlack, U Wolfrum, et al.Human Gene Therapy|February 4, 2011
Mesenchymal stromal cells for graft-versus-host diseaseJakub Tolar, Pierre Villeneuve, Armand KeatingHuman Gene Therapy|January 21, 2011
The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectorsDavid W EmeryHuman Gene Therapy|January 26, 2011
Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cellsChung Heon Ryu, Sang-Hoon Park, Soon A Park, et al.Human Gene Therapy|January 26, 2011
Contributions of gene marking to cell and gene therapiesCecilia N Barese, Cynthia E DunbarHuman Gene Therapy|November 19, 2010
Current good manufacturing practice production of an oncolytic recombinant vesicular stomatitis viral vector for cancer treatmentL J Ausubel, M Meseck, I Derecho, et al.Human Gene Therapy|April 22, 2010
PED/PEA-15 modulates coxsackievirus-adenovirus receptor expression and adenoviral infectivity via ERK-mediated signals in glioma cellsGinevra Botta, Giuseppe Perruolo, Silvana Libertini, et al.Human Gene Therapy|July 16, 2010
Use of a bioamplification assay to detect nonselective recombinants and assess the genetic stability of oncolytic adenovirusesShian-Jiun Shih, Emily Miyashita-Lin, Wan-Ju Tseng, et al.Human Gene Therapy|July 8, 2010
CD40-targeted recombinant adenovirus significantly enhances the efficacy of antitumor vaccines based on dendritic cells and B cellsYun-Sun Kim, Yeon-Jeong Kim, Jung-Mi Lee, et al.Pageof 413